Related Experiment Video
Updated: Aug 31, 2025

14:36
Combining QD-FRET and Microfluidics to Monitor DNA Nanocomplex Self-Assembly in Real-Time
Published on: August 26, 2009
11.2K
Nanoflare Couple: Multiplexed mRNA Imaging and Logic-Controlled Combinational Therapy
Yanjing Yang1, Tong Luo1, Yao He1
1College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, P. R. China.
Analytical Chemistry
|August 25, 2022
Summary
This study introduces a novel nanotheranostic platform for simultaneous cancer mRNA imaging and targeted gene/photothermal therapy. The nanoflare couple (NC) system demonstrates effective in vitro and in vivo breast cancer treatment.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Research
Background:
- Theranostics, combining diagnosis and therapy, is crucial for personalized cancer treatment but faces challenges.
- Developing integrated platforms for simultaneous molecular imaging and targeted therapy remains an unmet need.
Purpose of the Study:
- To develop a versatile nanotheranostic platform, termed nanoflare couple (NC), for in situ multiplex cancer-related mRNA imaging.
- To achieve logic-controlled gene therapy and photothermal therapy for breast cancer treatment.
Main Methods:
- Designed the NC platform utilizing TK1 and survivin mRNAs as targets for imaging and therapy triggers.
- Employed gold nanoparticles aggregation for therapeutic response upon infrared light irradiation.
- Validated efficacy using in vitro and in vivo assays in a mouse model with MCF-7 breast cancer cells.
Main Results:
- The NC platform enabled multiplexed mRNA imaging of cancer-related biomarkers.
- Demonstrated high efficiency in logic-controlled combinational therapy (gene and photothermal therapy).
- Successfully treated breast cancer in a preclinical mouse model.
Conclusions:
- The developed nanoflare couple (NC) platform offers a promising theranostic approach for personalized cancer treatment.
- This integrated system provides simultaneous molecular imaging and targeted therapeutic intervention.
- The NC platform shows significant potential for advancing breast cancer therapy.

